San Francisco Sentry Investment Group’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-6
| Closed | -$17K | – | 874 |
|
|
2018
Q1 | $17K | Buy |
6
+1
| +20% | +$2.83K | ﹤0.01% | 616 |
|
|
2017
Q4 | $24K | Hold |
5
| – | – | 0.01% | 543 |
|
|
2017
Q3 | $43K | Hold |
5
| – | – | 0.01% | 457 |
|
|
2017
Q2 | $23K | Buy |
5
+2
| +67% | +$9.2K | 0.01% | 443 |
|
|
2017
Q1 | $16K | Buy |
3
+1
| +50% | +$5.33K | 0.01% | 196 |
|
|
2016
Q4 | $16K | Buy |
2
+1
| +100% | +$8K | 0.01% | 186 |
|
|
2016
Q3 | $21K | Buy |
+1
| New | +$21K | 0.01% | 166 |
|